Hayne, D., Zhang, A. Y., Thomas, H., McCombie, S. P., Hawks, C., Anderson, P., Bastick, P. A., Beardsley, E. K., Green, W., Frydenberg, M., Grummet, J., Ischia, J., Krieger, L., Mitterdorfer, A., Patel, M., Sengupta, S., Srivastav, R. K., Redfern, A. D., Davis, I. D., Stockler, M. R. (2025). Mitomycin plus BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: A randomized phase 3 trial (ANZUP 1301).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba4504